CENTRAL TRUST Co lifted its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 8,932 shares of the company’s stock ...

The feature-length film from Sensodyne profiled several subjects in the neurodivergent and sensory sensitivity space, ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Shares of Haleon plc (NYSE:HLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the ...

The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...

When consumers don’t feel culturally represented in online advertising, they’re less likely purchase from certain brands.

Haleon-owned over-the-counter pain medication Panadol is making an effort to be more inclusive in its messaging.

Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.

Barclays analyst Iain Simpson maintained a Buy rating on Haleon PLC (HLN – Research Report) today and set a price target of £4.15. The ...

On Sunday, Haleon PLC – ADR (HLN) stock saw a decline, ending the day at $9.47 which represents a decrease of $-0.10 or -1.04% from the prior close of $9.57. The stock opened at $9.37 and touched a ...